Ephedrine and phenylephrine

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching PubMed

ephedrine phenylephrine spinal anesthesia hypotension

I now have comprehensive data from multiple authoritative sources. Here is a full comparative overview:

Ephedrine vs. Phenylephrine

1. Chemical Classification & Mechanism of Action

FeatureEphedrinePhenylephrine
ClassNoncatecholamine phenylisopropylamineNoncatecholamine synthetic sympathomimetic
MechanismMixed-acting — indirect (displaces NE from presynaptic vesicles) + direct α and β agonismDirect-acting — selective α₁ agonist only
Receptor profileα₁, α₂, β₁, β₂ (all adrenoceptors)Almost exclusively α₁
Dependence on NE storesYes — requires intact NE stores; blocked by reserpine/cocaineNo — acts directly on postsynaptic receptor
Mechanistic detail (Barash): Ephedrine is endocytosed into adrenergic nerve terminals where it displaces NE from synaptic vesicles. Released NE then activates postsynaptic receptors. Phenylephrine lacks a hydroxyl group on the phenyl ring (unlike epinephrine), which abolishes β-receptor activity.

2. Cardiovascular Effects

ParameterEphedrinePhenylephrine
Blood pressure↑ (via ↑CO + ↑SVR)↑ (via ↑SVR alone)
Heart rate↑ (β₁ stimulation)↓ (reflex bradycardia via baroreceptors)
Cardiac output↓ or unchanged (normal LV)
SVRVariable increaseMarked increase
ContractilityNo direct effect
ArrhythmogenicityYes (β₁ effect)No — not arrhythmogenic
Ephedrine resembles epinephrine in its initial cardiovascular profile — raising HR, CO, and SVR together. Phenylephrine raises BP solely by vasoconstriction; baroreceptor activation then slows the heart. — Barash, Clinical Anesthesia, 9e
In heart failure (HFrEF): Phenylephrine can precipitate a drop in CO because the failing ventricle is very sensitive to afterload increases. Ephedrine is generally preferred in this context.

3. Tachyphylaxis

  • Ephedrine: Rapid tachyphylaxis occurs with repeated dosing because presynaptic NE stores are depleted and ephedrine itself is released as a "false neurotransmitter."
  • Phenylephrine: Also subject to tachyphylaxis with infusions, requiring upward titration — but the mechanism is receptor desensitization, not NE depletion.

4. Pharmacokinetics

ParameterEphedrinePhenylephrine
BioavailabilityHigh (orally active)Parenteral or topical for systemic use
Duration (IV bolus)Longer (minutes–hours)~15 min
Half-life3–6 hShort
EliminationUrinary excretion largely unchangedHepatic
CNS penetrationYes — CNS stimulantMinimal

5. Clinical Uses

Ephedrine

  • Hypotension during anesthesia (especially when accompanied by bradycardia — the classic indication)
  • Hypotension from spinal/neuraxial anesthesia
  • Bronchodilation (largely replaced by selective β₂ agonists)
  • Urinary continence (stimulates α receptors at bladder neck)
  • Nasal congestion (decongestant)

Phenylephrine

  • Hypotension with normal or elevated heart rate (opposite indication to ephedrine)
  • Spinal anesthesia–induced hypotension — preferred agent for prophylactic infusion in cesarean delivery
  • Nasal decongestant (oral/topical; has replaced pseudoephedrine in many OTC products)
  • Mydriasis (ophthalmic drops)
  • Paroxysmal supraventricular tachycardia (reflex vagal slowing)

6. Neuraxial Anesthesia & Obstetrics (Key Clinical Comparison)

This is the most clinically discussed head-to-head comparison:
"Ephedrine and phenylephrine are the most used vasopressors for prevention and treatment of hypotension associated with neuraxial anesthesia. In parturients during cesarean section, ephedrine raises blood pressure primarily by increasing stroke volume and cardiac output. Phenylephrine increases systemic vascular resistance and decreases cardiac output." — Barash, Clinical Anesthesia, 9e
Fetal/neonatal relevance: Phenylephrine is now generally preferred in obstetric spinal anesthesia because ephedrine crosses the placenta and can stimulate fetal metabolism, leading to lower fetal pH (fetal acidosis). Phenylephrine does not have this effect to the same degree.
Prophylactic infusion vs. bolus (phenylephrine): A prophylactic phenylephrine infusion results in fewer interventions and less nausea than rescue bolus dosing. — Barash, Clinical Anesthesia, 9e

7. Side Effects & Adverse Effects

EphedrinePhenylephrine
HypertensionYes (can be marked)Yes (dose-dependent)
TachycardiaYesNo (causes bradycardia)
ArrhythmiasRisk present (β₁ stimulation)Minimal arrhythmia risk
CNS stimulationYes — insomnia, anxietyNo
Urinary retentionYes (α receptor at bladder neck; especially in BPH)Minimal
Reflex bradycardiaNoYes — clinically significant
Pulmonary hypertensionLess concernCan ↑ pulmonary artery pressures
Hypertensive headacheYes (with overdose)Yes (with large doses)

8. Contraindications / Cautions

EphedrinePhenylephrine
Cardiovascular diseaseCaution — arrhythmias, unrecognized coronary diseaseCaution — afterload-sensitive states (HFrEF)
MAO inhibitor useContraindicated — severe hypertensive crisisAlso caution
BPHCaution — urinary retentionLess concern
BradycardiaGood choice (raises HR)Avoid — worsens bradycardia
TachycardiaAvoid — raises HR furtherPreferred choice

9. Dosing (Clinical Anesthesia Context)

EphedrinePhenylephrine
IV bolus5–25 mg50–100 mcg (0.5–1 mcg/kg)
Infusion5–25 mg/h (titrated)25–100 mcg/min (titrated)
ConcentrationTypically 5 mg/mLUsually diluted to 100 mcg/mL from 1% solution

10. Summary: When to Choose Each

SituationPreferred Agent
Hypotension + bradycardiaEphedrine
Hypotension + tachycardiaPhenylephrine
Spinal anesthesia in cesarean deliveryPhenylephrine (better fetal outcomes)
Bronchospasm with hypotensionEphedrine
Pure vasoplegia (vasodilatory shock)Phenylephrine
Known cardiac dysfunction (HFrEF)Caution with phenylephrine; prefer ephedrine or inotropes
Mydriasis neededPhenylephrine (topical)
Nasal decongestionBoth available; phenylephrine OTC

Sources: Morgan & Mikhail's Clinical Anesthesiology, 7e | Barash, Cullen & Stoelting's Clinical Anesthesia, 9e | Goodman & Gilman's Pharmacological Basis of Therapeutics | Katzung's Basic & Clinical Pharmacology, 16e | Lippincott Illustrated Reviews: Pharmacology

Can you make not of individual drug include moa, pharmacokinetics, indications, adv effect, dose interaction

Checking Date & Time
Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Running Command

mkdir -p /home/daytona/workspace/pharmacology-notes && ls /home/daytona/workspace/pharmacology-notes/

Writing File

~/pharmacology-notes/generate_notes.py

from reportlab.lib.pagesizes import A4
from reportlab.lib import colors
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
    HRFlowable, KeepTogether
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER
from reportlab.platypus import PageBreak

OUTPUT = "/home/daytona/workspace/pharmacology-notes/Ephedrine_Phenylephrine_Notes.pdf"

doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    leftMargin=2*cm, rightMargin=2*cm,
    topMargin=2*cm, bottomMargin=2*cm
)

styles = getSampleStyleSheet()

# Custom styles
TITLE = ParagraphStyle("Title", parent=styles["Title"],
    fontSize=20, textColor=colors.HexColor("#1a1a2e"), spaceAfter=6,
    alignment=TA_CENTER, fontName="Helvetica-Bold")

SUBTITLE = ParagraphStyle("Subtitle", parent=styles["Normal"],
    fontSize=11, textColor=colors.HexColor("#555555"),
    spaceAfter=18, alignment=TA_CENTER, fontName="Helvetica-Oblique")

DRUG_HEADER = ParagraphStyle("DrugHeader",
    fontSize=16, textColor=colors.white, fontName="Helvetica-Bold",
    alignment=TA_LEFT, spaceAfter=0, spaceBefore=0,
    leftIndent=8)

SECTION = ParagraphStyle("Section",
    fontSize=11, textColor=colors.HexColor("#1a1a2e"), fontName="Helvetica-Bold",
    spaceBefore=10, spaceAfter=4, leftIndent=0)

BODY = ParagraphStyle("Body", parent=styles["Normal"],
    fontSize=9.5, leading=14, textColor=colors.HexColor("#222222"),
    fontName="Helvetica", spaceAfter=3, leftIndent=8)

BULLET = ParagraphStyle("Bullet", parent=styles["Normal"],
    fontSize=9.5, leading=14, textColor=colors.HexColor("#222222"),
    fontName="Helvetica", spaceAfter=2, leftIndent=16, bulletIndent=8)

TABLE_HEADER = ParagraphStyle("TH", fontSize=9, fontName="Helvetica-Bold",
    textColor=colors.white, alignment=TA_CENTER)
TABLE_CELL = ParagraphStyle("TC", fontSize=9, fontName="Helvetica",
    textColor=colors.HexColor("#222222"), alignment=TA_LEFT, leading=12)

FOOTER_TEXT = ParagraphStyle("Footer", fontSize=8, textColor=colors.grey,
    alignment=TA_CENTER, fontName="Helvetica-Oblique")

# ── Colours
EPHEDRINE_BG = colors.HexColor("#2e4057")
PHENYL_BG    = colors.HexColor("#048a81")
SECTION_LINE = colors.HexColor("#cccccc")
TABLE_HDR_BG = colors.HexColor("#2e4057")
ALT_ROW      = colors.HexColor("#f0f4f8")

def drug_header(name, subtitle):
    data = [[Paragraph(name, DRUG_HEADER), Paragraph(subtitle, ParagraphStyle(
        "Sub2", fontSize=10, textColor=colors.HexColor("#dddddd"),
        fontName="Helvetica-Oblique", alignment=TA_LEFT))]]
    bg = EPHEDRINE_BG if "Ephedrine" in name else PHENYL_BG
    t = Table(data, colWidths=[9*cm, 8*cm])
    t.setStyle(TableStyle([
        ("BACKGROUND", (0,0), (-1,-1), bg),
        ("ROWBACKGROUNDS", (0,0), (-1,-1), [bg]),
        ("TOPPADDING",    (0,0), (-1,-1), 10),
        ("BOTTOMPADDING", (0,0), (-1,-1), 10),
        ("LEFTPADDING",   (0,0), (-1,-1), 10),
        ("RIGHTPADDING",  (0,0), (-1,-1), 6),
        ("VALIGN",        (0,0), (-1,-1), "MIDDLE"),
        ("ROUNDEDCORNERS", (0,0), (-1,-1), [6,6,6,6]),
    ]))
    return t

def section_title(text):
    return [
        Paragraph(f"▸  {text}", SECTION),
        HRFlowable(width="100%", thickness=0.5, color=SECTION_LINE, spaceAfter=4),
    ]

def bullets(items):
    return [Paragraph(f"• {item}", BULLET) for item in items]

def mini_table(headers, rows, col_widths=None):
    if col_widths is None:
        col_widths = [17*cm / len(headers)] * len(headers)
    header_row = [Paragraph(h, TABLE_HEADER) for h in headers]
    data = [header_row]
    for i, row in enumerate(rows):
        data.append([Paragraph(str(c), TABLE_CELL) for c in row])
    t = Table(data, colWidths=col_widths, repeatRows=1)
    ts = [
        ("BACKGROUND", (0,0), (-1,0), TABLE_HDR_BG),
        ("TEXTCOLOR",  (0,0), (-1,0), colors.white),
        ("FONTNAME",   (0,0), (-1,0), "Helvetica-Bold"),
        ("FONTSIZE",   (0,0), (-1,0), 9),
        ("TOPPADDING",    (0,0), (-1,-1), 5),
        ("BOTTOMPADDING", (0,0), (-1,-1), 5),
        ("LEFTPADDING",   (0,0), (-1,-1), 6),
        ("RIGHTPADDING",  (0,0), (-1,-1), 6),
        ("GRID",       (0,0), (-1,-1), 0.4, colors.HexColor("#cccccc")),
        ("VALIGN",     (0,0), (-1,-1), "TOP"),
    ]
    for i in range(1, len(data)):
        if i % 2 == 0:
            ts.append(("BACKGROUND", (0,i), (-1,i), ALT_ROW))
    t.setStyle(TableStyle(ts))
    return t

# ─────────────────────────────────────────────
# BUILD CONTENT
# ─────────────────────────────────────────────
story = []

# TITLE PAGE
story.append(Spacer(1, 1.5*cm))
story.append(Paragraph("Pharmacology Notes", TITLE))
story.append(Paragraph("Ephedrine  &  Phenylephrine — Mechanism, Pharmacokinetics, Indications, Adverse Effects, Dosing & Drug Interactions", SUBTITLE))
story.append(HRFlowable(width="100%", thickness=1.5, color=EPHEDRINE_BG, spaceAfter=6))
story.append(Paragraph("Sources: Morgan & Mikhail Clinical Anesthesiology 7e · Barash Clinical Anesthesia 9e · Goodman & Gilman 14e · Katzung 16e · Lippincott Illustrated Reviews Pharmacology", FOOTER_TEXT))
story.append(Spacer(1, 0.5*cm))

# ══════════════════════════════════════════════
# DRUG 1 — EPHEDRINE
# ══════════════════════════════════════════════
story.append(drug_header("1.  Ephedrine", "Mixed-acting sympathomimetic · Noncatecholamine phenylisopropylamine"))
story.append(Spacer(1, 0.3*cm))

# MOA
story += section_title("Mechanism of Action")
story += bullets([
    "Mixed-acting sympathomimetic: predominantly indirect, with direct component.",
    "Indirect mechanism: endocytosis into adrenergic nerve terminals → displaces norepinephrine (NE) from synaptic vesicles → released NE activates postsynaptic α and β receptors.",
    "Direct mechanism: directly stimulates α₁, α₂, β₁, and β₂ adrenoceptors.",
    "Net receptor profile: α₁ + α₂ + β₁ + β₂ (all adrenoceptors).",
    "Because it depends on presynaptic NE stores, drugs depleting NE (e.g., reserpine) or blocking uptake (e.g., cocaine) attenuate its effects.",
    "Tachyphylaxis: rapid depletion of presynaptic NE stores with repeated dosing; ephedrine is released as a false neurotransmitter.",
    "CNS penetrant — mild stimulant (unlike catecholamines).",
])
story.append(Spacer(1, 0.2*cm))

# PHARMACOKINETICS
story += section_title("Pharmacokinetics")
story.append(mini_table(
    ["Parameter", "Detail"],
    [
        ["Route", "Oral (high bioavailability), IV, IM"],
        ["Onset (IV)", "~1 min"],
        ["Duration (IV bolus)", "10–60 min (longer than direct-acting catecholamines)"],
        ["Half-life", "3–6 hours"],
        ["Metabolism", "Minor hepatic; not metabolised by MAO or COMT (unlike catecholamines)"],
        ["Elimination", "Renal excretion — largely unchanged drug in urine"],
        ["CNS penetration", "Yes — crosses blood-brain barrier; mild CNS stimulant"],
    ],
    col_widths=[5*cm, 12*cm]
))
story.append(Spacer(1, 0.2*cm))

# INDICATIONS
story += section_title("Indications")
story += bullets([
    "Hypotension during anesthesia — preferred when accompanied by bradycardia.",
    "Spinal / neuraxial anesthesia-induced hypotension (when heart rate is low or normal).",
    "Bronchospasm / asthma — largely superseded by selective β₂ agonists.",
    "Urinary incontinence (stress) — stimulates α receptors at bladder neck.",
    "Nasal decongestant (oral / topical).",
    "Narcolepsy / myasthenia gravis (historical use).",
    "Intraoperative: vasopressor of choice when hypotension + bradycardia coexist.",
])
story.append(Spacer(1, 0.2*cm))

# ADVERSE EFFECTS
story += section_title("Adverse Effects")
story.append(mini_table(
    ["System", "Effect"],
    [
        ["Cardiovascular", "Hypertension, tachycardia, palpitations, arrhythmias (β₁ stimulation)"],
        ["CNS", "Insomnia, anxiety, tremor, headache, CNS stimulation"],
        ["Genitourinary", "Urinary retention — especially in BPH patients (α receptor activation at bladder neck)"],
        ["Tachyphylaxis", "Rapid tolerance with repeated doses due to NE depletion from nerve terminals"],
        ["Metabolic", "Hyperglycaemia (β₂ effect on glycogenolysis)"],
        ["Obstetric concern", "Crosses placenta → fetal tachycardia and fetal acidosis (lower umbilical pH)"],
        ["Overdose", "Severe hypertension, arrhythmias, haemorrhagic stroke"],
        ["Regulatory", "FDA banned ephedra-containing dietary supplements (safety concerns, deaths reported)"],
    ],
    col_widths=[4*cm, 13*cm]
))
story.append(Spacer(1, 0.2*cm))

# DOSING
story += section_title("Dosing (Clinical Anesthesia / Inpatient)")
story.append(mini_table(
    ["Route / Indication", "Dose"],
    [
        ["IV bolus (anesthesia-induced hypotension)", "5–25 mg; titrate to effect"],
        ["IV infusion", "25–50 mg in 250 mL → titrate 5–25 mg/h"],
        ["IM", "25–50 mg"],
        ["Oral (decongestant)", "25–50 mg every 4 h (max 150 mg/day)"],
    ],
    col_widths=[7*cm, 10*cm]
))
story.append(Spacer(1, 0.2*cm))

# DRUG INTERACTIONS
story += section_title("Drug Interactions")
story.append(mini_table(
    ["Drug / Class", "Interaction", "Clinical Consequence"],
    [
        ["MAO inhibitors (phenelzine, tranylcypromine)",
         "MAO normally breaks down displaced NE; MAOIs block this → massive NE accumulation",
         "Severe hypertensive crisis; potentially fatal. Avoid — use direct-acting agents instead."],
        ["Tricyclic antidepressants (TCAs)",
         "TCAs block NE reuptake transporter (NET) → augmented pressor response to released NE",
         "Exaggerated hypertension; arrhythmias. Use with extreme caution; reduce dose."],
        ["β-blockers",
         "Block β₁/β₂ effects of ephedrine → unopposed α stimulation",
         "Paradoxical hypertension and bradycardia; reduced bronchodilation."],
        ["Volatile anaesthetics (halothane)",
         "Sensitise myocardium to catecholamines",
         "Increased arrhythmia risk — use cautiously."],
        ["Reserpine / α-methyldopa",
         "Deplete presynaptic NE stores",
         "Attenuated or absent response to ephedrine (loss of indirect action)."],
        ["Cocaine",
         "Blocks NE reuptake transporter, preventing ephedrine uptake into nerve terminal",
         "Reduced indirect effect; unpredictable pressor response."],
        ["Tocolytics (β-sympathomimetics, e.g., ritodrine)",
         "Additive β stimulation",
         "Increased risk of arrhythmias and cardiovascular instability — use cautiously in labour."],
        ["Oxytocin",
         "Synergistic vasoconstriction in some vascular beds",
         "Monitor blood pressure closely in obstetric patients."],
        ["Theophylline",
         "Additive β₂ and CNS stimulation",
         "Risk of arrhythmias and seizures."],
        ["Digoxin",
         "Increased sympathetic tone may worsen digoxin-related arrhythmias",
         "Cardiac monitoring required."],
    ],
    col_widths=[4.5*cm, 6.5*cm, 6*cm]
))
story.append(Spacer(1, 0.4*cm))

# ══════════════════════════════════════════════
# DRUG 2 — PHENYLEPHRINE
# ══════════════════════════════════════════════
story.append(PageBreak())
story.append(drug_header("2.  Phenylephrine", "Direct-acting selective α₁ agonist · Noncatecholamine"))
story.append(Spacer(1, 0.3*cm))

# MOA
story += section_title("Mechanism of Action")
story += bullets([
    "Direct-acting, selective α₁ adrenoceptor agonist — does NOT depend on presynaptic NE stores.",
    "Structural difference from epinephrine: lacks the 4-hydroxyl group on the phenyl ring → abolishes β-receptor activity.",
    "Activates α₁ on vascular smooth muscle → Gq coupling → ↑ intracellular Ca²⁺ → actin-myosin shortening → vasoconstriction.",
    "Constricts venous capacitance vessels, cutaneous, skeletal muscle, mesenteric, splenic, and renal vasculature → ↑ LV preload and afterload → ↑ arterial pressure.",
    "Baroreceptor-mediated reflex bradycardia (vagal tone increases in response to ↑ BP).",
    "NOT arrhythmogenic — no β-receptor stimulation of myocardium.",
    "Pulmonary vasoconstriction → ↑ pulmonary artery pressures.",
])
story.append(Spacer(1, 0.2*cm))

# PHARMACOKINETICS
story += section_title("Pharmacokinetics")
story.append(mini_table(
    ["Parameter", "Detail"],
    [
        ["Routes", "IV bolus, IV infusion, topical intranasal, ophthalmic, oral (decongestant — limited systemic absorption)"],
        ["Onset (IV)", "< 1 min"],
        ["Duration (IV bolus)", "~15 min"],
        ["Half-life (IV)", "~2–3 min (redistribution); terminal t½ ~2–3 h"],
        ["Metabolism", "Hepatic (MAO and COMT independent — not a catechol); also intestinal MAO"],
        ["Elimination", "Renal; metabolised to inactive glucuronide conjugates"],
        ["CNS penetration", "Minimal — does not cross BBB readily"],
    ],
    col_widths=[5*cm, 12*cm]
))
story.append(Spacer(1, 0.2*cm))

# INDICATIONS
story += section_title("Indications")
story += bullets([
    "Hypotension during anesthesia with normal or elevated heart rate (e.g., after vasodilating agents).",
    "Spinal / neuraxial anesthesia-induced hypotension — preferred agent in obstetric (cesarean) spinal anesthesia; prophylactic infusion reduces nausea and physician interventions.",
    "Paroxysmal supraventricular tachycardia (PSVT) — reflex vagal slowing can terminate SVT.",
    "Nasal decongestant: topical spray or oral; has replaced pseudoephedrine in many OTC products.",
    "Mydriasis: ophthalmic drops for pupil dilation during fundoscopy.",
    "Hypotension in patients on PDE5 inhibitors (e.g., after sildenafil + nitrate interaction) — used as vasopressor of last resort.",
    "Septic shock (as vasopressor when tachyarrhythmias preclude other agents).",
    "Refractory hypotension in cases where β stimulation is undesirable (e.g., HOCM, aortic stenosis).",
])
story.append(Spacer(1, 0.2*cm))

# ADVERSE EFFECTS
story += section_title("Adverse Effects")
story.append(mini_table(
    ["System", "Effect"],
    [
        ["Cardiovascular", "Reflex bradycardia (can be severe); increased pulmonary artery pressure"],
        ["Cardiac output", "May ↓ CO in patients with HFrEF — failing ventricle is afterload-sensitive"],
        ["Renal / splanchnic", "Renal and mesenteric vasoconstriction with high doses"],
        ["Tissue ischaemia", "Risk of peripheral ischaemia with prolonged infusion"],
        ["Hypertensive headache", "With large doses"],
        ["Ophthalmic", "Prolonged mydriasis; angle-closure glaucoma risk in predisposed patients"],
        ["Tachyphylaxis", "With infusions — mechanism: receptor desensitisation; requires dose titration upward"],
        ["Nasal rebound", "Rhinitis medicamentosa with prolonged topical use (> 3 days)"],
        ["Spinal additive", "As spinal adjuvant: associated with transient neurological symptoms (TNS)"],
    ],
    col_widths=[4*cm, 13*cm]
))
story.append(Spacer(1, 0.2*cm))

# DOSING
story += section_title("Dosing (Clinical Anesthesia / Inpatient)")
story.append(mini_table(
    ["Route / Indication", "Dose"],
    [
        ["IV bolus (adult anesthesia-induced hypotension)", "50–100 mcg (0.5–1 mcg/kg); repeat every 1–2 min PRN"],
        ["IV infusion (prophylaxis / treatment)", "25–100 mcg/min; titrate to target MAP"],
        ["Preparation", "Dilute 1% solution (10 mg/mL ampule) → 100 mcg/mL working solution"],
        ["Obstetric prophylactic infusion", "25–50 mcg/min; start at induction of spinal block"],
        ["Intranasal (decongestant)", "0.25–0.5% solution — 2–3 sprays per nostril every 4 h (max 3 days)"],
        ["Ophthalmic (mydriasis)", "2.5% or 10% solution — 1 drop; 10% avoided in elderly / infants"],
        ["SVT (historical)", "0.5–1 mg IV slow push — largely replaced by adenosine"],
    ],
    col_widths=[7*cm, 10*cm]
))
story.append(Spacer(1, 0.2*cm))

# DRUG INTERACTIONS
story += section_title("Drug Interactions")
story.append(mini_table(
    ["Drug / Class", "Interaction", "Clinical Consequence"],
    [
        ["MAO inhibitors",
         "MAO is a minor metabolic pathway for phenylephrine; MAOIs prolong and intensify action",
         "Exaggerated hypertension; use with caution and at reduced doses."],
        ["Tricyclic antidepressants",
         "TCAs block NET → augmented response to direct α₁ stimulation",
         "Severe hypertension with even small doses; reduce dose significantly."],
        ["β-blockers (non-selective)",
         "Unopposed α stimulation when β-mediated vasodilation is blocked",
         "Paradoxical hypertension and reflex bradycardia worsened."],
        ["PDE5 inhibitors (sildenafil, tadalafil)",
         "PDE5 inhibitors cause profound vasodilation; phenylephrine used to counteract hypotension from PDE5i + nitrate interaction",
         "Phenylephrine is vasopressor of choice in this setting; titrate carefully."],
        ["Oxytocin",
         "Additive vasoconstrictive effects",
         "Monitor BP closely in post-partum patients."],
        ["Guanethidine / reserpine",
         "NE depletion has no effect on phenylephrine (direct-acting) — no attenuation",
         "Unlike ephedrine, phenylephrine response is preserved."],
        ["Halogenated anaesthetics",
         "Phenylephrine does not sensitise myocardium (no β effect) — advantage over ephedrine",
         "Lower arrhythmia risk compared to ephedrine in volatile anaesthetic context."],
        ["Ergot alkaloids (ergometrine)",
         "Additive vasoconstriction",
         "Risk of severe peripheral and coronary vasospasm — avoid combination."],
        ["Atropine",
         "Blocks reflex bradycardia caused by phenylephrine",
         "Useful if bradycardia is problematic; heart rate may rise substantially."],
        ["α-blockers (prazosin, phentolamine)",
         "Competitive antagonism at α₁ receptors",
         "Attenuated or abolished vasoconstrictor response."],
    ],
    col_widths=[4.5*cm, 6.5*cm, 6*cm]
))
story.append(Spacer(1, 0.4*cm))

# ══════════════════════════════════════════════
# QUICK COMPARISON TABLE
# ══════════════════════════════════════════════
story.append(PageBreak())
story.append(Paragraph("Quick Comparison Summary", ParagraphStyle("QC", fontSize=14,
    textColor=colors.HexColor("#1a1a2e"), fontName="Helvetica-Bold",
    spaceBefore=8, spaceAfter=10, alignment=TA_CENTER)))

story.append(mini_table(
    ["Feature", "Ephedrine", "Phenylephrine"],
    [
        ["Class", "Noncatecholamine, phenylisopropylamine", "Noncatecholamine, synthetic"],
        ["Mechanism", "Mixed (indirect + direct)", "Direct only"],
        ["Receptor profile", "α₁, α₂, β₁, β₂ (all)", "α₁ only"],
        ["Depends on NE stores?", "Yes", "No"],
        ["Heart rate", "↑ (β₁)", "↓ (reflex bradycardia)"],
        ["Cardiac output", "↑", "↓ or unchanged"],
        ["SVR", "↑ (variable)", "↑↑ (primary effect)"],
        ["Arrhythmogenicity", "Yes (β₁ stimulation)", "No"],
        ["CNS effects", "Stimulant (insomnia, anxiety)", "Minimal"],
        ["Duration (IV)", "10–60 min", "~15 min"],
        ["Half-life", "3–6 h", "Short (2–3 min redistribution)"],
        ["Tachyphylaxis mechanism", "NE depletion from terminals", "Receptor desensitisation"],
        ["Preferred in bradycardia?", "Yes", "No (worsens it)"],
        ["Preferred in tachycardia?", "No", "Yes"],
        ["Obstetric spinal anesthesia", "Causes fetal acidosis — less preferred", "Preferred; better fetal pH"],
        ["Mydriasis", "Not used", "Yes (topical)"],
        ["Decongestant", "Yes (oral/topical)", "Yes (oral/topical; OTC)"],
        ["Key interaction", "MAOIs → hypertensive crisis (indirect mechanism)", "TCAs → exaggerated hypertension"],
    ],
    col_widths=[5*cm, 6*cm, 6*cm]
))

story.append(Spacer(1, 0.6*cm))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.grey))
story.append(Spacer(1, 0.2*cm))
story.append(Paragraph(
    "References: Morgan & Mikhail's Clinical Anesthesiology 7e | Barash, Cullen & Stoelting's Clinical Anesthesia 9e | "
    "Goodman & Gilman's Pharmacological Basis of Therapeutics 14e | Katzung's Basic and Clinical Pharmacology 16e | "
    "Lippincott Illustrated Reviews: Pharmacology | Miller's Anesthesia 10e",
    FOOTER_TEXT
))

# BUILD
doc.build(story)
print(f"PDF saved to: {OUTPUT}")
You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.